captopril has been researched along with alpha-synuclein in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adeyemi, O; Afolayan, O; Badru, A; Ishola, I; John, N; Olubodun-Obadun, T | 1 |
1 other study(ies) available for captopril and alpha-synuclein
| Article | Year |
|---|---|
Angiotensin converting enzyme inhibitor captopril prevents neuronal overexpression of amyloid-beta and alpha-synuclein in Drosophila melanogaster genetic models of neurodegenerative diseases.
Topics: alpha-Synuclein; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Drosophila melanogaster; Humans; Models, Genetic; Neurodegenerative Diseases; Neurons | 2022 |